Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
ProductsNeurocloud VOL

Vendor source

Reviewed 11 May 2026

Completeness Strong (67%)

Neurocloud VOL

Qubiotech

Neurocloud VOL provides volumetric analysis for atrophy and lesion quantification in MRI. It assists in the follow-up and evolution of neurodegenerative pathologies.
- MRI T1: identifies atrophy in the patient's brain. Clinically relevant brain structures are segmented and volumetric data from the patient's brain is compared with the normality distribution.
- FLAIR: identifies inflammatory lesions and hyperintense regions in white matter, and presents results in graphics and images for both the evolution of the atrophy and the growth/decrease of the lesions and the appearance of new lesions.

No papers to support — we monitor for new evidence.

Neurocloud VOL

Key Features

  • Atrophy and white matter lessions identification
  • Brain roi segmentation
  • Longitudinal analysis
  • Normative comparison
  • Number and clasification of lesions
  • White and grey matter quantification

General Information

Product name

Neurocloud VOL

Company

Modality

MR

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Multiple Sclerosis (MS), epilepsy, dementia, Alzheimer's disease (AD)

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class I

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

Technical Specifications

Patient population age

Not specified

Input

T1 and FLAIR MR (3D, non-contrast)

Input format

DICOM

Output

Table of quantified values, segmentation overlay, analysis by regions of interest, graphic identification of ROIs, voxel-to-voxel parametric analysis, customizable report

Output format

DICOM, EXCEL, NIFTI, PDF

Integration

Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)

Trigger for analysis

On demand, triggered by a user through e.g. a button click, image upload

Processing time

1 - 10 minutes

Population

Patients with a brain 3D T1 MR from 18 to 90yo.

Market Presence

On market since

01-2019

AI Platforms

Alma Health Platform

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Customizable plans, Subscription

Based on

Customizable plans, Number of analyses, Number of installations

Source: Vendor | First published: Sep 10, 2023 | Last updated: May 11, 2026

Neurocloud VOL - Qubiotech